FERRONE, MARCO

FERRONE, MARCO

Rete di Collaborazioni Statistiche Email Alert RSS Feed

Dettaglio

	
			Nome completo
		
			FERRONE, MARCO 	  	
			
			Afferenza
		
			EX-Dipartimento di Ingegneria Chimica, dell'Ambiente e delle Materie prime-(1900/2009) 	  	
			
			SSD
		
			Settore ING-IND/24 - Principi di Ingegneria Chimica

Pubblicazioni

Risultati 1 - 20 di 105 (tempo di esecuzione: 0.001 secondi).

1
2
3
4
5
6

	Titolo	Data di pubblicazione	Autori	File
1	A cyclodextrin-bioconjugate as carrier for anticancer drugs: from synthesis to molecular modeling	2002	PRICL, SABRINA ; FERMEGLIA, MAURIZIO ; FERRONE, MARCO ; Lodi A.; Caliceti P.; Salmaso S.; Fornasier R.	-
2	A new mutation affecting the ATP pocket of kit receptor in patients with GIST showing acquired resistance to Imatinib: A coupled experimental and modeling investigation	2004	PRICL, SABRINA ; Coslanich A.; FERMEGLIA, MAURIZIO ; FERRONE, MARCO ; PANENI, Maria Silvia ; Tamborini E.; Pilotti S.; Pierotti M. A.	-
3	A new twist for an old song. The DABO story revisited	2006	PRICL, SABRINA ; FERRONE, MARCO ; POSOCCO, PAOLA ; Pavan G. M.; FERMEGLIA, MAURIZIO ; La Colla P.; Loddo R.	-
4	A simple but effective three-dimensional chemical feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA-polymerase inhibitors	2005	DI SANTO R.; FERMEGLIA, MAURIZIO ; FERRONE, MARCO ; PANENI, Maria Silvia ; COSTI R.; ARTICO M.; ROUX A.; GABRIELE M.; TARDIFF K. D.; SIDDIQUI A.; PRICL, SABRINA	-
5	A talk on the motor side. The free energy for mutating V186 and F244 to Leucine in beta-myosin and its ATP binding	2004	PANENI, Maria Silvia ; FERRONE, MARCO ; Coslanich A:; FERMEGLIA, MAURIZIO ; PRICL, SABRINA ; Miertus S.; Frecer V.; Carniel E.; Mestroni L.	-
6	A Tumor (GIST), a Mutated Gene (c-kit), and a Molecular Inhibitor (Imatinib): Insights from Computer Simulations	2003	PRICL, SABRINA ; Coslanich A.; FERMEGLIA, MAURIZIO ; FERRONE, MARCO ; Albertini V.; Bonadiman L.; Tamborini E.; Pierotti M. A.; Pilotti S.	-
7	Alternative Refrigerants: Thermophysical Properties and Phase equilibra by computational chemistry	2002	FERMEGLIA, MAURIZIO ; FERRONE, MARCO ; PRICL, SABRINA	-
8	Analogies in imatinib-resistant threonine-to-isoleucine mutation in bcr-abl, kit and pdgfra: a combined experimental/computational approach	2004	PRICL, SABRINA ; COSLANICH, ALESSANDRO ; FERMEGLIA, MAURIZIO ; Ferro M.; FERRONE, MARCO ; PANENI, Maria Silvia ; Tamborini E.; Negri T.; Lagonigro S.; Greco A.; Gabanti E.; Pierotti M. A.; Pilotti S.	-
9	Angels and demons of the guardian of the genome. A coupled modeling-biochemical study of p53 mutants in ovarian cancer.	2006	PRICL, SABRINA ; FERRONE, MARCO ; PANENI, Maria Silvia ; Cosoli P.; FERMEGLIA, MAURIZIO ; Perrone F.; Da Riva L.; Tamborini E.; Suardi S.; Pierotti M. P.; Pilotti S.	-
10	Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach	2006	BANFI, ELENA ; SCIALINO G.; ZAMPIERI, DANIELE ; MAMOLO, MARIA GRAZIA ; VIO, LUCIANO ; FERRONE, MARCO ; FERMEGLIA, MAURIZIO ; PANENI M. S.; PRICL, SABRINA	-
11	Antifungal and antimycobacterial activity of new N1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: a combined experimental and computational approach	2004	MAMOLO, MARIA GRAZIA ; ZAMPIERI, DANIELE ; FALAGIANI V; VIO, LUCIANO ; FERMEGLIA, MAURIZIO ; FERRONE, MARCO ; PRICL, SABRINA ; BANFI, ELENA ; SCIALINO G.	-
12	Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations	2005	MAMOLO, MARIA GRAZIA ; ZAMPIERI, DANIELE ; VIO, LUCIANO ; FERMEGLIA, MAURIZIO ; FERRONE, MARCO ; PRICL, SABRINA ; SCIALINO G; BANFI, ELENA	-
13	Binding at the core. Computational study of structural and ligand binding properties of naphthiridine based dendrimers	2007	POSOCCO, PAOLA ; FERRONE, MARCO ; FERMEGLIA, MAURIZIO ; PRICL, SABRINA	-
14	C-kit mutants in GISTs and their interaction with STI 571: Insights from computer simulations and clinical trials.	2003	PRICL, SABRINA ; FERRONE, MARCO ; FERMEGLIA, MAURIZIO ; E. Tamborini; D. Delia; M. A. Pierotti; S. Pilotti	-
15	Can computational structural biology be of help in rationalizing clinical data? The Abl/imatinib paradigm	2005	PRICL, SABRINA ; Tamborini E.; FERRONE, MARCO ; PANENI, Maria Silvia ; FERMEGLIA, MAURIZIO ; Pierotti M. A.; Pilotti S.	-
16	Can inhibitors of HIV integrase work on HCV polymerase?	2002	Artico M.; Costi R.; Di Santo R.; FERMEGLIA, MAURIZIO ; FERRONE, MARCO ; Manfredini S.; PRICL, SABRINA	-
17	Changes and challenges: GIST, mutated C-KIT and imatinib resistance	2005	PRICL, SABRINA ; FERRONE, MARCO ; PANENI, Maria Silvia ; Cosoli P.; FERMEGLIA, MAURIZIO ; Pierotti M. A.; Pilotti S.; Tamborini E.	-
18	Chasing the evaders. Design, synthesis, activity and molecular modelling of a new small molecule with activity against drug-resistant HIV-1-mutants	2006	PRICL, SABRINA ; FERRONE, MARCO ; POSOCCO, PAOLA ; FERMEGLIA, MAURIZIO ; Sanna G.; Collu G.; La Colla P.; Loddo R.; Sias A.; Piras S.; Carta A.	-
19	Chemical Engineering at the edge of life science. Selected cases of molecular simulations and free-energy calculations for biological and medical applications.	2002	FERRONE, MARCO ; FERMEGLIA, MAURIZIO ; PRICL, SABRINA	-
20	Computational alanine scanning to probe DNA - Wild type and mutant p53 interactions.	2003	PRICL, SABRINA ; FERRONE, MARCO ; FERMEGLIA, MAURIZIO ; L. Laurent; E. Tamborini; D. Delia; M. A. Pierotti; S. Pilotti	-

1
2
3
4
5
6